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Introduction
The Ductus Arteriosus (DA) is an important vascular connection 
between the main pulmonary artery and the aorta. During fetal 
life, the DA diverts blood from the pulmonary artery into the aorta, 
thereby bypassing the lungs. After birth, the DA undergoes active 
constriction and eventual obliteration. A Patent Ductus Arteriosus 
(PDA) occurs when the ductus fails to completely close after delivery. 
Fetal patency is regulated by low oxygen tension and prostanoids, 
predominantly Prostaglandin E2 (PGE2) and Prostacyclin (PGI2). 
PGE2 and PGI2 levels are high in the fetus because of both placental 
production and diminished clearance by the fetal lungs [1]. After birth 
at term, a postnatal increase in PaO2 and a decrease in circulating 
vasodilators such as PGE2 and PGI2 will induce constriction of DA 
smooth muscle cells and, consequently, functional closure of the 
ductus in newborns [2].
The incidence of PDA in term infants has been estimated to be 57 
per 1,00,000 live births [3], whereas one in every three preterm infant 
with a birth weight of 501 to 1500 g (very low birth weight [VLBW]) 
can be expected to have a PDA [4,5], contributing to significant 
morbidity and mortality in preterm infants. The shunting of blood 
through a PDA in premature infants is essentially all left-to-right. 
Subsequently there is an excessive flow through pulmonary 
circulation and hypoperfusion of the systemic circulation. As such, 
preterm infants born at <1500 g are susceptible to hypoperfusion 
of vital organs and resultant additional co-morbidities such as IVH 
(Intraventricular hemorrhage), periventricular leukomalacia, NEC, 
and (pre) renal failure. However, although PDA is definitely associated 
with these morbidities, its causal role is not clear [6]. 
The higher incidence of PDA in preterm infants may be explained 
by the effect of prematurity on the regulators of ductal tone [7]. In 
preterm infants, sensitivity for oxygen is reduced while the sensitivity 
to PGE2, nitric oxide (NO), and perhaps endothelin 1 is increased [8].
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Summary
Background: Patent Ductus Arteriosus (PDA) is the most common heart disease among the newborn population. 
Besides prematurity, other factors are believed to play a significant role in this condition.
Aims: Identification of perinatal risk factors associated with PDA in premature or Very Low Birth Weight Infants 
(VLBW).
Material and methods: Transversal study including all infants admitted to a Level III Neonatal Intensive Care 
Unit, from January 2005 to December 2009 and included in the Very Low Birth Weight Portuguese National Database . 
Clinical and demographic data were analysed using a logistic regression analysis to identify risk factors for PDA. 
Results: A total of 318 VLBW or less than 32 weeks Gestational Age (GA) infants were enrolled, 53.6% males. 
Infants presenting PDA (100; 31.4%) had a lower mean BW ( 914,19 versus 1257,44 grams; p<0.001) and a lower 
mean GA (27.06 versus 29.77 weeks; p<0.0001). 
Using univariate logistic regression, both lower BW [OR: 0.99; CI (95%): 0.995-0.997] and lower GA [OR: 0.68; CI 
(95%): 0.61-0.75] were important risk factors for PDA.
Other factors increasing the risk of PDA were: lower Apgar scores at one [OR: 0.77; CI (95%): 0.68-0.86] and 
five minutes [OR:0.73;CI (95%): 0.62-0.86]; need for resuscitation in the delivery room [OR: 13.1;CI(95%):3.11-55.1]; 
surfactant administration [OR:8.12;CI(95%):4.13-15.95]; higher CRIB score [OR:1.17;CI(95%): 1.11-1.24], and higher 
SNAPPEII score [OR: 1.03; CI (95%): 1.02-1.04].
The logistic multivariate regression model using all these variables identified BW [OR: 0.997; CI (95%): 0.996-
0.998] and surfactant treatment [OR: 3.99; CI (95%): 1.903-8.386] as the only risk factors contributing with statistical 
significance.
The analysis of the ROC curve showed a predictive positive value of 82%. 
Discussion: The most important risk factors were the use of surfactant and BW, the latter increasing by 23%, the 
risk of PDA for fewer 100 grams. Although surfactant treatment leads to improved respiratory outcomes and survival in 
VLBW infants, it increased the risk of PDA by an almost fourfold.
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Glucocorticoids appear to change DA’s sensitivity to PGE2. For 
example, hydrocortisone given to preterm lambs facilitates ductal 
constriction, probably by decreasing the sensitivity of the ductus 
to the dilating action of PGE2 [9]. This may explain the lower 
incidence of PDA in VLBW infants whose mothers received antenatal 
glucocorticoid treatment [10].
As per the above, mechanisms underlying the functional closure 
of the DA depend on gestational maturity. Nevertheless, other factors 
are believed to play a significant role to this condition.
The aim of this article is to identify other perinatal risk factors 
associated with PDA in premature or very low birth weight infants.
Material and Methods 
All infants admitted to our NICU from January 2005 to December 
2009 and included in the Very Low Birth Weight Portuguese National 
Database were enrolled for a transversal study. The study took place 
in a level III Neonatal Intensive Care Unit at the Pediatric Department 
of Professor Fernando Fonseca Hospital, Portugal. We used data 
pertaining to our NICU that is included in the National Very Low 
Birth Weight database.
PDA was diagnosed with echocardiogram. Clinical and 
demographic data were analysed. The differences between groups 
(with/without PDA) were analyzed applying the Chi-square, 
T-student or Mann-Whitney tests. Risk and protective factors were 
identified through the Odds Ratio (OR) obtained with the univariate 
and multivariate logistic regression. The multivariate logistic model 
was built using the forward method. The discriminatory power of the 
model was evaluated using the ROC curve, including the concordance 
index (area under the curve). The statistical tests were carried out at a 
significance level of 0.05 using the SPSS 17 software. 
Results 
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Figure 1:  PDA according to birth weight and gestational age.
Variables OR CI 95% p
Lower Upper
Gender 1.15 0.71 1.85 0.55
Gestational age (days) 0.68 0.61 0.75 <0.0001
Birth weight (grams) 0.99 0.995 0.997 <0.0001
APGAR 1’ 0.77 0.68 0.86 <0.0001
APGAR 5’ 0.73 0.62 0.86 <0.0001
CRIB 1.17 1.11 1.24 <0.0001
SNAPPE II 1.03 1.02 1.04 <0.0001
Resuscitation delivery room 13.1 3.11 55.1 <0.0001
Surfactant administration 8.12 4.13 15.95 <0.0001
Antenatal corticotherapy 0.81 0.44 1.49 0.50
Table 2: Univariate Logistic Regression analysis for PDA risk and protective factors.
A total of 318 infants with very low birth weight or less than 32 
weeks gestational age were enrolled, of which 53.6% were males. The 
mean birth weight and gestational age were 1139, 2 grams and 29 
weeks  respectively (Table 1).
PDA was diagnosed by echocardiogram in 100 infants (31.4%) 
NO  PDA
( N= 218)
PDA
( N= 100)
p
Gender  (female/male) 119/99 51/49 0.31 (b)
Antenatal  corticotherapy 177 (81.2%) 80 (80%) 0.4 (b)
Gestational  age (mean± SD) 29.7 ± 2.82 weeks 27.06 ± 2.37 weeks <0.001 (a)
Birth Weight  (mean± SD) 1257.44 ± 326 
grams
914.19 ± 278 
grams
<0.001(a)
Surfactant administration 80 (36.7%) 78 (78%) <0.001 (b)
APGAR 1’ (mean rank) 175.9 116.8 <0.001(c)
APGAR 5’ (mean rank) 176.0 116.6 <0.001 (c)
CRIB (mean ± SD) 2.58 ± 4.12 5.91 ± 4.45 <0.001 (a)
SNAPPE II (mean± SD) 27.41 ± 25.4 48.67 ± 25.5 <0.001 (a)
Resuscitation with O2 171(78.4%) 97 (97%) <0.001 (b)
Manual ventilation 70 (32.1%) 39 39%) 0.14 (b)
Intubation 82 (61.9%) 76 (48.1%) <0.001 (b)
Epinhefrine 7 (3.2%) 6 (6%) 0.4 (b)
Chest compressions 12 (5.5%) 10 (10%) 0.2 (b)
pa : Two-tailed T-test - analysis of variance of values 
pb: Chi-square test comparison between groups 
pc : Mann-Whitney U test
SD: standard deviation
Table 1: Baseline characteristics of study infants.
who presented clinical criteria for PDA: murmur, bouncing pulses, 
prominent left ventricular impulse or noncardiovascular findings 
such as tachypnea, apnea, increased carbon dioxide retention or 
increased requirements for mechanical ventilation, unexplained by 
lung disease.
Infants with PDA had a lower mean birth weight (914.19 versus 
1257.44 grams; p<0.001) and a lower mean gestational age (27.06 
versus 29.77 weeks; p<0,0001) (Figure 1).
Using an univariate logistic regression analysis (Table 2), lower 
gestational age and lower birth weight were risk factors for PDA. The 
higher Apgar scores at one and five minutes decreased the risk of PDA 
by 23% and 27%, respectively. Need for resuscitation in the delivery 
room (manual ventilation, oxygen, intubation, chest compressions or 
adrenaline) as well as the clinical and mortality CRIB and SNAPPEII 
scoring systems were also risk factors at a significant level. The 
administration of surfactant increased by eightfold the risk of PDA.
Antenatal corticotherapy was not a protective factor for PDA.
The multivariate logistic regression model, adjusted for gestational 
age and using all these variables, identified birth weight [OR:0.997; CI 
(95%):0.996-0.998] and use of surfactant [OR: 3.99; CI (95%): 1.903-
8.386] as the only risk factors contributing with statistical significance 
(Table 3). We also evaluated the Area Under the Curve (AUC) and 
reported a PPV of 82% (Figure 2).
Discussion
Identification of risk factors for the patency of the DA is important 
not only because a persistent patent ductus arteriosus (PDA) in 
preterm infants can have significant clinical consequences, but also 
because treatment is not without complications. 
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The prevalence of PDA in our sample was 31.4%, which is in 
accordance to the literature [11].
It is known that the mechanisms underlying functional DA 
closure depend on gestational maturity [1]. When using the univariate 
logistic regression, both lower gestational age (OR: 0.32; IC: 0.61-0.75) 
and lower birth weight (OR: 0.01; CI: 0.995-0.997) represented risk 
factors, the risk of PDA increasing 29% for every less 100 grams and 
93% for every week less of gestational age. In fact, in our study, birth 
weight represented a more significant risk factor than gestational age, 
given that Portuguese National Database included not only VLBW, 
but also less than 32 weeks infants, thus making birth weight a more 
representative parameter of prematurity.
Lower Apgar score at one (OR: 0.77; CI: 0.68-0.86) and at five 
minutes (OR: 0.73; CI: 0.62-0.86) were also risk factors, i.e. for one 
less Apgar point the PDA risk increases by 23 and 27%, respectively. 
Ressuscitation in the delivery room (manual ventilation, oxygen, 
intubation, chest compressions or adrenaline) (OR 13,1; CI:3,11-55,1) 
represented a risk factor at a significant level [12]. 
The lower Apgar scores and the need for resuscitation can either 
be a manifestation of the infant’s immaturity or caused by an acute 
obstetric condition such as asphyxia. Reller et al. [13] also found that 
in VLBW infants, birth asphyxia and severe RDS were significant 
risk factors for development of an early hemodynamically significant 
PDA.
Accordingly, the neonatal scoring systems CRIB (OR: 1,17; CI: 
1.11-1.24), and SNAPPEII (OR: 1,03; CI: 1.02-1.04) also increased the 
risk of PDA. Besides immaturity and severity of illness frequently 
presented by preterm infants, other parameters, namely, the Apgar 
score, presence of metabolic acidosis and need for supplemental 
oxygen are also considered when scoring [14], all contributing to PDA, 
as noted above [13]. 
In our study, surfactant administration (OR: 8,12; CI: 4.13-
15.95) increased by eightfolds the risk of PDA. Although the effects 
Although steroids seem to change DA’s sensitivity to PGE2, in 
our study, antenatal corticotherapy (OR: 0,81; CI: 0.44- 1.49) was not 
identified as a protective factor for PDA, probably due to the size of 
the sample.
When undertaking the multivariate logistic regression analysis 
adjusted to gestational age, only the birth weight (OR: 0,997; CI: 
0.996-0.998) and the administration of surfactant (OR: 3,99; CI: 
1.903-8.386) remained significant risk factors. These facts underline 
not only the importance of immaturity in the pathophysiology of PDA 
but also the likely effect of surfactant administration on pulmonary 
and systemic hemodynamics. The model used proved to be a good 
fit to predict PDA, as the AUC corresponded to a predictive positive 
value of 82%, considered an excellent discrimination model [18]. 
Conclusion
Although with limitations resulting from its retrospective nature, 
this study confirmed the importance of identifying risk factors for 
PDA acting individually or in interaction with each other.
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